PDS Biotechnology clinical trials we track

Check company identity source

Phase 3 1 trial

Phase 2 1 trial

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 252 participants (planned). After: 12 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Feb 2029. After: 25 Aug 2026.

Recruitment status changed

Before: Active not recruiting. After: Terminated.

Check registry source

· 2 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Overall Survival (OS). After: Measure: Overall Survival (OS) Measure: Progression-Free Survival (PFS).

Planned enrollment decreased by 99 participants

Before: 351 participants (planned). After: 252 participants (planned).

Check registry source